Dynorphin 1 - 13

Developed for: opiate dependence · substance withdrawal syndrome
Investigated by: National Institute on Drug Abuse (NIDA) · University of Minnesota

today NCT00000244 · Ph 2

1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT00000244	Aug 1994 → Mar 1997	opiate dependence, substance withdrawal syndrome	University of Minnesota	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Dynorphin 1 - 13	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000244 ↗
Route	Intravenous	“single IV dose” NCT00000244 ↗